Mougiakakou Stavroula G, Bartsocas Christos S, Bozas Evangelos, Chaniotakis Nikos, Iliopoulou Dimitra, Kouris Ioannis, Pavlopoulos Sotiris, Prountzou Aikaterini, Skevofilakas Marios, Tsoukalis Alexandre, Varotsis Kostas, Vazeou Andrianni, Zarkogianni Konstantia, Nikita Konstantina S
Institute of Communication and Computer Systems, National Technical University of Athens, Athens 15780, Greece.
IEEE Trans Inf Technol Biomed. 2010 May;14(3):622-33. doi: 10.1109/TITB.2009.2039711. Epub 2010 Jan 29.
SMARTDIAB is a platform designed to support the monitoring, management, and treatment of patients with type 1 diabetes mellitus (T1DM), by combining state-of-the-art approaches in the fields of database (DB) technologies, communications, simulation algorithms, and data mining. SMARTDIAB consists mainly of two units: 1) the patient unit (PU); and 2) the patient management unit (PMU), which communicate with each other for data exchange. The PMU can be accessed by the PU through the internet using devices, such as PCs/laptops with direct internet access or mobile phones via a Wi-Fi/General Packet Radio Service access network. The PU consists of an insulin pump for subcutaneous insulin infusion to the patient and a continuous glucose measurement system. The aforementioned devices running a user-friendly application gather patient's related information and transmit it to the PMU. The PMU consists of a diabetes data management system (DDMS), a decision support system (DSS) that provides risk assessment for long-term diabetes complications, and an insulin infusion advisory system (IIAS), which reside on a Web server. The DDMS can be accessed from both medical personnel and patients, with appropriate security access rights and front-end interfaces. The DDMS, apart from being used for data storage/retrieval, provides also advanced tools for the intelligent processing of the patient's data, supporting the physician in decision making, regarding the patient's treatment. The IIAS is used to close the loop between the insulin pump and the continuous glucose monitoring system, by providing the pump with the appropriate insulin infusion rate in order to keep the patient's glucose levels within predefined limits. The pilot version of the SMARTDIAB has already been implemented, while the platform's evaluation in clinical environment is being in progress.
SMARTDIAB是一个旨在通过结合数据库(DB)技术、通信、模拟算法和数据挖掘领域的先进方法,来支持1型糖尿病(T1DM)患者的监测、管理和治疗的平台。SMARTDIAB主要由两个单元组成:1)患者单元(PU);2)患者管理单元(PMU),它们相互通信以进行数据交换。PU可以通过互联网使用设备(如具有直接互联网接入的个人电脑/笔记本电脑或通过Wi-Fi/通用分组无线服务接入网络的手机)访问PMU。PU由一个用于向患者皮下输注胰岛素的胰岛素泵和一个连续血糖测量系统组成。上述运行用户友好应用程序的设备收集患者的相关信息并将其传输到PMU。PMU由糖尿病数据管理系统(DDMS)、一个为长期糖尿病并发症提供风险评估的决策支持系统(DSS)和一个驻留在Web服务器上的胰岛素输注咨询系统(IIAS)组成。DDMS可供医务人员和患者使用,并具有适当的安全访问权限和前端接口。DDMS除了用于数据存储/检索外,还提供用于智能处理患者数据的高级工具,支持医生在患者治疗决策方面的工作。IIAS用于通过向胰岛素泵提供适当的胰岛素输注速率,以使患者的血糖水平保持在预定义范围内,从而闭合胰岛素泵和连续血糖监测系统之间的回路。SMARTDIAB的试点版本已经实施,而该平台在临床环境中的评估正在进行中。